<?xml version="1.0" encoding="UTF-8"?>
<p>There are multiple accounts of these genetic polymorphisms resulting in resistant strains of malaria because of abnormalities in metabolism [
 <xref rid="B112-antioxidants-09-00636" ref-type="bibr">112</xref>,
 <xref rid="B113-antioxidants-09-00636" ref-type="bibr">113</xref>,
 <xref rid="B114-antioxidants-09-00636" ref-type="bibr">114</xref>]. These same gene polymorphisms affect heart failure patients since the CYP 2D6 gene is responsible for the metabolism of metoprolol [
 <xref rid="B115-antioxidants-09-00636" ref-type="bibr">115</xref>,
 <xref rid="B116-antioxidants-09-00636" ref-type="bibr">116</xref>]. This polymorphism affect many other drugs such as Isoniazid (INH), barbiturates, omeprazole, selective serotonin reuptake inhibitors (SSRIâ€™s), sulfasalazine, hydralazine, etc. [
 <xref rid="B75-antioxidants-09-00636" ref-type="bibr">75</xref>].
</p>
